Doravirine and the Potential for CYP3A-Mediated Drug–Drug Interactions

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02016-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vitro Evaluation of the Drug Interaction Potential of Doravirine

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Potential Drug-Drug Interactions Among Hospitalized Cardiac Patients

International Journal of Basic and Clinical Pharmacology
2016English

Potential Drug-Drug Interactions in Heart Failure Patients

International Journal of Pharmacy and Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2019English

Potential Drug-Drug Interactions in the Psychiatric Hospital: Frequency Analysis

Research Results in Pharmacology
2019English

OATP1B1-related Drug–drug and Drug–gene Interactions as Potential Risk Factors for Cerivastatin-Induced Rhabdomyolysis

Pharmacogenetics and Genomics
Molecular MedicineGeneticsMolecular Biology
2013English

Correction to "Prediction of Drug-Drug Interactions Arising From CYP3A Induction Using a Physiologically Based Dynamic Model"

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2016English

Drug-Drug Interactions Between Atorvastatin and Dronedarone Mediated by Monomeric CYP3A4

Biochemistry
Biochemistry
2017English

Pharmacy Students' Ability to Identify Potential Drug-Drug Interactions

American Journal of Pharmaceutical Education
PharmacologyPharmacyMedicineToxicologyEducationPharmaceutics
2009English

Prevalence of Potential Drug-Drug Interactions in Swedish Pediatric Outpatients

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy